for King County Bar Association
1. Sanofi-Aventis United States LLC v. Sandoz, Inc., 2009-1427, -1444, UNITED STATES COURT OF APPEALS FOR THE FEDERAL CIRCUIT, September 10, 2009, Decided
OVERVIEW: A district court erred in its construction of a claim of a patent because the claim was not limited to optically pure oxaliplatin produced by the high performance liquid chromatography process. The district court erred in construing composition claims as product-by-process claims, and its judgment of noninfringement was vacated.
If you are not a registered lexisONE® Community user, you will be asked to register.
Registration is free.